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Abstract: 
Next-generation vaccines for tuberculosis should be designed to prevent the infection 
and to achieve sterile eradication of Mycobacterium tuberculosis. Mucosal vaccination 
is a needle-free vaccine strategy that provides protective immunity against pathogenic 
bacteria and viruses in both mucosal and systemic compartments, being a promising 
alternative to current tuberculosis vaccines. Micro and nanoparticles have shown great 
potential as delivery systems for mucosal vaccines. In this review, the immunological 
principles underlying mucosal vaccine development will be discussed, and the 
application of mucosal adjuvants and delivery systems to the enhancement of protective 
immune responses at mucosal surfaces will be reviewed, in particular those envisioned 
for oral and nasal routes of administration. An overview of the essential vaccine 
candidates for tuberculosis in clinical trials will be provided, with special emphasis on 
the potential different antigens and immunization regimens.  
Keywords: ADJUVANTS; MICROPARTICLES; MUCOSAL IMMUNITY; 
NANOPARTICLES; TUBERCULOSIS VACCINES; VACCINE DELIVERY 
SYSTEMS  
Document Type: Review Article 
DOI: http://dx.doi.org/10.1166/jbn.2014.1984 
Publication date: 1 de Setembro de 2014 
 
